Murilo Freitas – Página 82

Fresenius Kabi Issues Voluntary Recall of Sodium Acetate Injection, USP Due to the Presence of Particulate Matter

Murilo Freitas - 05:00, 6 de marzo de 2022463

Fresenius Kabi USA is voluntarily recalling seven lots of Sodium Acetate Injection, USP, 400 mEq/100 mL (4 mEq/mL), 100 mL fill in a 100 mL vial to the user level due to the presence of particulate matter found in reserve and/or stability sample vials. Microscopic and elemental analyses determined t

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/fresenius-kabi-issues-voluntary-recall-sodium-acetate-injection-usp-due-presence-particulate-matter

rss-es

B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection USP 250ML in Excel Due to Fluid Leakage or Low Fill Volume

Murilo Freitas - 05:00, 2 de marzo de 2022351

B. Braun Medical Inc. (B. Braun) is voluntarily recalling five (5) lots of 0.9% Sodium Chloride for Injection USP 250ML in Excel within the United States to the hospital/user level.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/b-braun-medical-inc-issues-voluntary-nationwide-recall-09-sodium-chloride-injection-usp-250ml-excel

rss-es

Do Not Use Certain Celltrion DiaTrust COVID-19 Tests: FDA Safety Communication

Murilo Freitas - 05:00, 1 de marzo de 2022366

The tests in a green and white box have not been authorized, cleared, or approved. The FDA is concerned about the risk of false results when using these tests.

http://www.fda.gov/medical-devices/safety-communications/do-not-use-certain-celltrion-diatrust-covid-19-tests-fda-safety-communication

rss-es

Febrero cierra con estadísticas COVID-19 a la baja

Murilo Freitas - 19:19, 28 de febrero de 2022354

Febrero cierra con estadísticas COVID-19 a la baja

Martes 1° de marzo, 2022. La semana epidemiológica 8 que abarcó del 20 al 26 de febrero registró 18.137 casos de COVID-19…

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/749-noticias-2022/2284-febrero-cierra-con-estadisticas-covid-19-a-la-baja

rss-es

Salud recuerda obligatoriedad de tercera dosis de vacuna Covid-19 para funcionarios públicos

Murilo Freitas - 17:00, 27 de febrero de 2022535

Salud recuerda obligatoriedad de tercera dosis de vacuna Covid-19 para funcionarios públicos

28 de febrero del 2022. El Ministerio de Salud recuerda a las entidades públicas la vigencia del Decreto Ejecutivo N° 43249-S de 7 de octubre de 2021…

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/749-noticias-2022/2283-salud-recuerda-obligatoriedad-de-tercera-dosis-de-vacuna-covid-19-para-funcionarios-publicos

rss rss-es rss-pt

FDA Advisory Panel Recommendations on Lifelong Surveillance and Long-Term Postmarket Data Collection for Patients with AAA Endovascular Aortic Repair – Letter to Health Care Providers

Murilo Freitas - 05:00, 27 de febrero de 2022354

Regular clinical follow-up and imaging is critical to detect EVAR device and treatment failures.

http://www.fda.gov/medical-devices/letters-health-care-providers/fda-advisory-panel-recommendations-lifelong-surveillance-and-long-term-postmarket-data-collection

rss-es

FDA Roundup: February 25, 2022

Murilo Freitas - 20:46, 24 de febrero de 2022441

FDA Roundup: February 25, 2022
http://www.fda.gov/news-events/press-announcements/fda-roundup-february-25-2022

rss-es

Plan Nacional fortalecerá la prevención, vigilancia y control de enfermedades transmitidas por vectores

Murilo Freitas - 19:16, 24 de febrero de 2022520

Plan Nacional fortalecerá la prevención, vigilancia y control de enfermedades transmitidas por vectoresn

25 de febrero, 2022. El Ministerio de Salud en conjunto con la Organización Panamericana de la Salud (OPS)…

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/746-noticias-2021/2282-plan-nacional-fortalecera-la-prevencion-vigilancia-y-control-de-enfermedades-transmitidas-por-vectores

rss rss-es rss-pt

FDA Approves Treatment for Wider Range of Patients with Heart Failure

Murilo Freitas - 17:35, 23 de febrero de 2022524

FDA Approves Treatment for Wider Range of Patients with Heart Failure
http://www.fda.gov/news-events/press-announcements/fda-approves-treatment-wider-range-patients-heart-failure

rss-es

Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication

Murilo Freitas - 05:00, 23 de febrero de 2022503

FDA reminds the public and health care providers that results from currently authorized SARS-CoV-2 antibody tests should not be used to evaluate a person’s level of immunity from COVID-19 at any time, and especially after the person received a COVID-19 vaccination.

http://www.fda.gov/medical-devices/safety-communications/antibody-testing-not-currently-recommended-assess-immunity-after-covid-19-vaccination-fda-safety